We are live on ! Find out more
DekaBank Deutsche Girozentrale

DekaBank Deutsche Girozentrale Portfolio holdings

AUM $59.2B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+13.78%
1 Year Est. Return
+26.02%
3 Year Est. Return
+92.08%
5 Year Est. Return
+125.09%
10 Year Est. Return
+457.34%
AUM
$16.8B
AUM Growth
+$1.68B
Cap. Flow
-$601M
Cap. Flow %
-3.58%
Top 10 Hldgs %
18.74%
Holding
1,305
New
129
Increased
549
Reduced
440
Closed
115

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$101M
2
TXN icon
Texas Instruments
TXN
+$84.9M
3
TSM icon
TSMC
TSM
+$77.7M
4
CSCO icon
Cisco
CSCO
+$59.3M
5
NEE icon
NextEra Energy
NEE
+$49.2M

Top Sells

Rank Stock Value
1
LIN icon
Linde
LIN
+$840M
2
PG icon
Procter & Gamble
PG
+$95.7M
3
BABA icon
Alibaba
BABA
+$57.3M
4
MRK icon
Merck
MRK
+$49.9M
5
TGT icon
Target
TGT
+$40.6M

Sector Composition

Rank Sector Weight
1 Technology 19.67%
2 Healthcare 16.73%
3 Financials 14.72%
4 Communication Services 9.74%
5 Industrials 8.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLL icon
1026
Collegium Pharmaceutical
COLL
$887M
$221K ﹤0.01%
13,200
+2,400
+22% +$38.4K
KN icon
1027
Knowles
KN
$3.32B
$218K ﹤0.01%
12,400
– –
MKSI icon
1028
MKS Inc
MKSI
$20.2B
$217K ﹤0.01%
2,349
– –
ADMS
1029
DELISTED
Adamas Pharmaceuticals
ADMS
$216K ﹤0.01%
9,400
+1,700
+22% +$15.3K
TWLO icon
1030
Twilio
TWLO
$38.2B
$214K ﹤0.01%
2,672
-590
-18% -$66.4K
PACB icon
1031
Pacific Biosciences
PACB
$363M
$213K ﹤0.01%
46,000
+8,500
+23% +$61.5K
ACHN
1032
DELISTED
Achillion Pharmaceuticals
ACHN
$211K ﹤0.01%
66,300
+12,000
+22% +$29.5K
VNDA icon
1033
Vanda Pharmaceuticals
VNDA
$299M
$209K ﹤0.01%
10,600
+2,000
+23% +$45.6K
SFUN
1034
DELISTED
Fang Holdings Limited American Depositary Shares (each representing ten Class A Ordinary Shares)
SFUN
$209K ﹤0.01%
+148
New +$11.3K
SPPI
1035
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$208K ﹤0.01%
9,200
-58,200
-86% -$623K
PGNX
1036
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$208K ﹤0.01%
26,500
+5,000
+23% +$22.6K
RIGL icon
1037
Rigel Pharmaceuticals
RIGL
$764M
$207K ﹤0.01%
6,250
+1,150
+23% +$26.3K
JE
1038
DELISTED
Just Energy Group Inc
JE
$207K ﹤0.01%
+2,088
New +$246K
AGM icon
1039
Federal Agricultural Mortgage
AGM
$2.55B
$206K ﹤0.01%
+2,654
New +$194K
OTEX icon
1040
Open Text
OTEX
$6.07B
$205K ﹤0.01%
5,177
-1,987
-28% -$72.7K
CNR
1041
Core Natural Resources Inc
CNR
$4.52B
$201K ﹤0.01%
+4,796
New +$168K
CBIO
1042
Crescent Biopharma
CBIO
$646M
$200K ﹤0.01%
134
+25
+23% +$28.6K
EGBN icon
1043
Eagle Bancorp
EGBN
$843M
$198K ﹤0.01%
3,692
-500
-12% -$27.3K
OIS icon
1044
Oil States International
OIS
$524M
$192K ﹤0.01%
+5,615
New +$95K
PBR icon
1045
Petrobras
PBR
$117B
$189K ﹤0.01%
18,000
-11,301
-39% -$179K
ERF
1046
DELISTED
Enerplus Corporation
ERF
$188K ﹤0.01%
15,000
– –
ACRS icon
1047
Aclaris Therapeutics
ACRS
$835M
$187K ﹤0.01%
12,700
+2,100
+20% +$13.9K
NVAX icon
1048
Novavax
NVAX
$1.3B
$185K ﹤0.01%
6,155
+1,100
+22% +$34.7K
INO icon
1049
Inovio Pharmaceuticals
INO
$72.9M
$184K ﹤0.01%
3,033
+541
+22% +$27.3K
SIGI icon
1050
Selective Insurance
SIGI
$5.65B
$184K ﹤0.01%
2,900
– –
40 41
42
43 44

Similar funds

Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Aviva
Aviva London, United Kingdom $59.6B AUM 28.44% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $58.4B AUM
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Cohen & Steers
Cohen & Steers New York $57.6B AUM 8.03% 1-Year Est. Return

DekaBank Deutsche Girozentrale's Q1 2019 Portfolio in Review

As of Q1 2019, DekaBank Deutsche Girozentrale held 1,305 positions worth $16.8B, up 11% from $15.1B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

DekaBank Deutsche Girozentrale withdrew a net $601M in Q1 2019, closing 115 positions and reducing 440 holdings. Its most notable exit was Linde, an estimated $840M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, DekaBank Deutsche Girozentrale opened a new position in Express Scripts Holding Company worth $46.5M.

  • DekaBank Deutsche Girozentrale's largest Q1 2019 buy was Express Scripts Holding Company: 521,657 shares worth $46.5M.
  • DekaBank Deutsche Girozentrale added most to Johnson & Johnson in Q1 2019, an estimated $101M increase.
  • DekaBank Deutsche Girozentrale's biggest Q1 2019 reduction was Procter & Gamble, cutting an estimated $95.7M.
  • DekaBank Deutsche Girozentrale fully exited Linde in Q1 2019, selling an estimated $840M.
  • DekaBank Deutsche Girozentrale's ten largest holdings make up 19% of its $16.8B portfolio in Q1 2019.
  • DekaBank Deutsche Girozentrale opened 129 new positions and closed 115 in Q1 2019.
  • DekaBank Deutsche Girozentrale's portfolio value rose 11% quarter-over-quarter to $16.8B.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2019, filed 10 May 2019.